CEO of Alvotech

Rasmus Rojkjaer

A photo of Rasmus Rojkjaer

Rojkjaer Rasmus leads the management team and is spearheading the creation of a new, fully-integrated specialty biopharmaceutical company. With his knowledge and expertise, Rasmus will help Alvotech become a global market leader in biogenerics through the development of high quality, cost-controlled biosimilar products.

With more than two decades of industry experience, Rasmus has a reputation for building and driving winning teams and developing capabilities in biopharmaceuticals. He established and led the creation of Mylan’s biologics growth drivers; and at Novo, held various management positions during its establishment in biopharmaceuticals.

Rasmus holds a Ph.D in Molecular Biology from the University of Michigan. He is a member of Alvotech’s and Alvogen’s Executive Boards and is based in Reykjavik, Iceland.

Meet us at .
Please tell us a little about yourself.

Meet Us - Events